TargetMol

AX20017

Product Code:
 
TAR-T7312
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7312-2mg2mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-5mg5mg£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-1mL1 mL * 10 mM (in DMSO)£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-10mg10mg£144.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-25mg25mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-50mg50mg£346.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7312-100mg100mg£485.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.
CAS:
329221-38-7
Formula:
C13H16N2O2S
Molecular Weight:
264.34
Pathway:
; Microbiology/Virology
Purity:
0.98
SMILES:
NC(=O)c1c(NC(=O)C2CC2)sc2CCCCc12
Target:
Antibacterial

References

Scherr N , Honnappa S , Kunz G , et al. Structural basis for the specific inhibition of protein kinase G, a virulence factor of Mycobacterium tuberculosis[J]. Proceedings of the National Academy of Sciences, 2007, 104(29):12151-12156. Rita Sz?kely, Frigyes W?czek, Istv?n Szabadkai, et al. A novel drug discovery concept for tuberculosis: Inhibition of bacterial and host cell signalling[J]. Immunology Letters, 2008, 116(2):225-231.